{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/6032233"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "In the context of metastatic disease, resistance to antiangiogenic agents arises through a range of mechanisms, including the development of alternative angiogenic pathways." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "e-cancer.fr" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/413576114"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/6032233"] } } }
